11 min read
Monthly FDA Guidance and Regulatory News Review - September 2026
This September 2026 regulatory update focuses on FDA’s new guidance on neonatal parenteral nutrition compounding and...
Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.
Learn More →
Join Veristat and other Oncology researchers, clinicians and patients at the ESMO 2016 Conference, focused on finding the most effective cancer treatment solutions available today. ESMO 2016 offers a top-notch scientific and educational program created by international experts in oncology. Some key topic areas include:
Veristat’s Theresa Bruce and Kath Clayton will be attending ESMO and will be on hand to discuss how Veristat can help you design and execute your cancer trials throughout Europe and North America.
Veristat has helped clients run hundreds of oncology clinical trials for novel drugs, biologics, vaccines, immuno-therapies and diagnostics. We know that even the simplest of clinical trials tasks are much more complex and requires skilled expertise to complete. Schedule a time to speak with Veristat at ESMO about the challenges you are trying to overcome with your oncology program.
11 min read
Oct 21, 2026 Veristat Blog
This September 2026 regulatory update focuses on FDA’s new guidance on neonatal parenteral nutrition compounding and...
8 min read
Sep 21, 2026 Veristat Blog
This August 2026 regulatory update focuses on the FDA finalizing three guidances addressing formal sponsor meetings,...